Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases
Dhruv Ahuja, Kuan-Hung Yeh, Sagar Patel, Han Hee Lee, Shane W. Goodwin, Virginia Solitano, Christopher Ma, Ashwin N. Ananthakrishnan, Namrata Singh, Vipul Jairath, Ronghui Xu, Siddharth Singh
Topics & Concepts
MedicineInternal medicineConcomitantInflammatory bowel diseaseMaceJanus kinaseGastroenterologyProportional hazards modelHazard ratioUlcerative colitisDiseaseConfidence intervalCytokineConventional PCIMyocardial infarctionInflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and Treatments